A comparison of maternal and fetal fentanyl concentration following fentanyl use in childbirth
Recruiting
- Conditions
- Childbirth
- Registration Number
- ACTRN12618001012268
- Lead Sponsor
- The University of South Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of fentanyl transfer across the placenta during childbirth?
How does intranasal fentanyl compare to subcutaneous administration in maternal and fetal drug concentration profiles?
Are there specific biomarkers that correlate with fentanyl distribution in maternal and umbilical cord plasma during labor?
What are the potential adverse events associated with fentanyl use in labor and how are they managed?
How does fentanyl pharmacokinetics in childbirth compare to other opioids like remifentanil or morphine in maternal-fetal transfer?